BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356]
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1356.htm
Number Citing Articles
1
Cheng Gao, Xiangzhen Liu, Wei Liu, Huaizhang Shi, Zhenhuan Zhao, Huirong Chen, Shiguang Zhao. Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in ratsAutonomic Neuroscience 2008; 141(1-2): 22 doi: 10.1016/j.autneu.2008.04.007
2
A-Man Xu, Lei Huang, Wei Liu, Shuang Gao, Wen-Xiu Han, Zhi-Jian Wei, Tone Frost Bathen. Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLoS ONE 2014; 9(1): e86941 doi: 10.1371/journal.pone.0086941
3
Rossella Reddavid, Silvia Sofia, Paolo Chiaro, Fabio Colli, Renza Trapani, Laura Esposito, Mario Solej, Maurizio Degiuli. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?World Journal of Gastroenterology 2018; 24(2): 274-289 doi: 10.3748/wjg.v24.i2.274
4
Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E. Slanger, Bryan Burmeister, David Kelsen, Donna Niedzwiecki, Christoph Schuhmacher, Susan Urba, Cornelis van de Velde, Thomas N. Walsh, Marc Ychou, Katrin Jensen. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate dataEuropean Journal of Cancer 2013; 49(15): 3149 doi: 10.1016/j.ejca.2013.05.029
5
U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz, P. Kienle, K. Nowak, M. Kieser, T.E. Slanger, B. Burmeister, D. Kelsen, D. Niedzwiecki, C. Schuhmacher, S. Urba, C. van de Velde, T.N. Walsh, M. Ychou, K. Jensen. Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)European Journal of Surgical Oncology (EJSO) 2017; 43(8): 1550 doi: 10.1016/j.ejso.2017.05.005
6
Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E Slanger, Katrin Jensen. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD008107.pub2
7
K. Kumagai, I. Rouvelas, J.A. Tsai, D. Mariosa, P.A. Lind, M. Lindblad, W. Ye, L. Lundell, C. Schuhmacher, M. Mauer, B.H. Burmeister, J.M. Thomas, M. Stahl, M. Nilsson. Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: A direct and adjusted indirect comparison meta-analysisEuropean Journal of Surgical Oncology (EJSO) 2015; 41(3): 282 doi: 10.1016/j.ejso.2014.11.039
8
Huiyu Luo, Liucheng Wu, Mingwei Huang, Qinwen Jin, Yuzhou Qin, Jiansi Chen. Postoperative morbidity and mortality in patients receiving neoadjuvant chemotherapy for locally advanced gastric cancersMedicine 2018; 97(43): e12932 doi: 10.1097/MD.0000000000012932
9
Tom van den Ende, Frank A. Abe Nijenhuis, Héctor G. van den Boorn, Emil ter Veer, Maarten C. C. M. Hulshof, Suzanne S. Gisbertz, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-AnalysisFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00684
10
Tom van den Ende, Emil ter Veer, Mélanie Machiels, Rosa Mali, Frank Abe Nijenhuis, Laura de Waal, Marety Laarman, Suzanne Gisbertz, Maarten Hulshof, Martijn van Oijen, Hanneke van Laarhoven. The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysisCancers 2019; 11(1): 80 doi: 10.3390/cancers11010080